These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21774092)

  • 41. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
    Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
    J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric neuroblastic tumors: A critical evaluation of cytomorphological features for risk stratification on aspiration cytology.
    Behera G; Chhabra G; Mishra P; Sable M
    Diagn Cytopathol; 2020 May; 48(5):464-474. PubMed ID: 32043835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical use of fine needle aspiration cytology for diagnosis and management of children with neuroblastic tumours.
    Fröstad B; Tani E; Kogner P; Maeda S; Björk O; Skoog L
    Eur J Cancer; 1998 Mar; 34(4):529-36. PubMed ID: 9713304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
    YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR: MYCN amplification as a marker for genomic instability in neuroblastomas.
    Muñoz J; Vendrell E; Aiza G; Nistal M; Pestaña A; Peinado MA; Castresana JS
    Neuropathology; 2006 Jun; 26(3):165-9. PubMed ID: 16771170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours.
    Uccini S; Colarossi C; Scarpino S; Boldrini R; Natali PG; Nicotra MR; Perla FM; Mannarino O; Altavista P; Boglino C; Cappelli CA; Cozzi D; Donfrancesco A; Kokai G; Losty PD; McDowell HP; Dominici C
    Br J Cancer; 2006 Jul; 95(1):49-55. PubMed ID: 16755292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo.
    Schulte JH; Pentek F; Hartmann W; Schramm A; Friedrichs N; Øra I; Koster J; Versteeg R; Kirfel J; Buettner R; Eggert A
    Int J Cancer; 2009 May; 124(10):2488-94. PubMed ID: 19142969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extra-adrenal peripheral neuroblastic tumors: A clinicopathological study of 18 cases.
    Shankaralingappa S; Patra S; Gami A; Trivedi P; Chalaliya AK
    Indian J Pathol Microbiol; 2023; 66(2):278-285. PubMed ID: 37077068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The stromal Schwann cell during maturation of peripheral neuroblastomas. Immunohistochemical observations with antibodies to the neuronal class III beta-tubulin isotype (beta III) and S-100 protein.
    Katsetos CD; Karkavelas G; Frankfurter A; Vlachos IN; Vogeley K; Schober R; Wechsler W; Urich H
    Clin Neuropathol; 1994; 13(4):171-80. PubMed ID: 7955661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Composite ganglioneuroblastoma. An assessment of the significance of histological maturation in neuroblastoma diagnosed beyond infancy.
    Bove KE; McAdams AJ
    Arch Pathol Lab Med; 1981 Jun; 105(6):325-30. PubMed ID: 6894529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Clin Cancer Res; 2003 Oct; 9(13):4835-40. PubMed ID: 14581355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma.
    Ambros IM; Zellner A; Roald B; Amann G; Ladenstein R; Printz D; Gadner H; Ambros PF
    N Engl J Med; 1996 Jun; 334(23):1505-11. PubMed ID: 8618605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. INSM1 Expression in Peripheral Neuroblastic Tumors and Other Embryonal Neoplasms.
    Wang H; Krishnan C; Charville GW
    Pediatr Dev Pathol; 2019 Oct; 22(5):440-448. PubMed ID: 30975032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transbronchial fine needle aspiration cytological examination: a useful tool for diagnosing primary lung cancer.
    Iyoda A; Baba M; Shibuya K; Moriya Y; Yasufuku K; Sekine Y; Iizasa T; Hiroshima K; Nakatani Y; Fujisawa T
    Thorac Cardiovasc Surg; 2006 Mar; 54(2):117-9. PubMed ID: 16541353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitosis-Karyorrhexis Index evaluation by digital image visual analysis for application of International Neuroblastoma Pathology Classification in FNA biopsy.
    Bhardwaj N; Rohilla M; Trehan A; Bansal D; Kakkar N; Srinivasan R
    Cancer Cytopathol; 2022 Feb; 130(2):128-135. PubMed ID: 34633743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GLUT1 protein expression correlates with unfavourable histologic category and high risk in patients with neuroblastic tumours.
    Ramani P; Headford A; May MT
    Virchows Arch; 2013 Feb; 462(2):203-9. PubMed ID: 23307190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.
    Fendler WP; Melzer HI; Walz C; von Schweinitz D; Coppenrath E; Schmid I; Bartenstein P; Pfluger T
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1701-10. PubMed ID: 23857458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.